381 related articles for article (PubMed ID: 19181251)
1. Optimized dose distribution of Gammamed plus vaginal cylinders.
Supe SS; Bijina TK; Varatharaj C; Shwetha B; Arunkumar T; Sathiyan S; Ganesh KM; Ravikumar M
Med Dosim; 2009; 34(1):20-5. PubMed ID: 19181251
[TBL] [Abstract][Full Text] [Related]
2. American Brachytherapy Society survey regarding practice patterns of postoperative irradiation for endometrial cancer: current status of vaginal brachytherapy.
Small W; Erickson B; Kwakwa F
Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1502-7. PubMed ID: 16109462
[TBL] [Abstract][Full Text] [Related]
3. Effects of prescription depth, cylinder size, treatment length, tip space, and curved end on doses in high-dose-rate vaginal brachytherapy.
Li S; Aref I; Walker E; Movsas B
Int J Radiat Oncol Biol Phys; 2007 Mar; 67(4):1268-77. PubMed ID: 17336226
[TBL] [Abstract][Full Text] [Related]
4. Postoperative intravaginal brachytherapy for endometrial cancer; dosimetric analysis of vaginal colpostats and cylinder applicators.
Kim RY; Pareek P; Duan J; Murshed H; Brezovich I
Brachytherapy; 2002; 1(3):138-44. PubMed ID: 15090276
[TBL] [Abstract][Full Text] [Related]
5. Comparison of high dose-rate and low dose-rate dose distributions for vaginal cylinders.
Gore E; Gillin MT; Albano K; Erickson B
Int J Radiat Oncol Biol Phys; 1995 Jan; 31(1):165-70. PubMed ID: 7995748
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic analysis of high-dose-rate (192)Ir vaginal cuff brachytherapy for endometrial cancer using a cylindrical target volume model and varied cancer cell distributions.
Zhang H; Donnelly ED; Strauss JB; Qi Y
Med Phys; 2016 Jan; 43(1):483. PubMed ID: 26745941
[TBL] [Abstract][Full Text] [Related]
7. Treatment volume and dose optimization of MammoSite breast brachytherapy applicator.
Dickler A; Kirk M; Choo J; Hsi WC; Chu J; Dowlatshahi K; Francescatti D; Nguyen C
Int J Radiat Oncol Biol Phys; 2004 Jun; 59(2):469-74. PubMed ID: 15145164
[TBL] [Abstract][Full Text] [Related]
8. Impact of "optimized" treatment planning for tandem and ring, and tandem and ovoids, using high dose rate brachytherapy for cervical cancer.
Noyes WR; Peters NE; Thomadsen BR; Fowler JF; Buchler DA; Stitt JA; Kinsella TJ
Int J Radiat Oncol Biol Phys; 1995 Jan; 31(1):79-86. PubMed ID: 7995771
[TBL] [Abstract][Full Text] [Related]
9. Dose and volume parameters for MRI-based treatment planning in intracavitary brachytherapy for cervical cancer.
Kirisits C; Pötter R; Lang S; Dimopoulos J; Wachter-Gerstner N; Georg D
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):901-11. PubMed ID: 15936576
[TBL] [Abstract][Full Text] [Related]
10. MRI-guided 3D optimization significantly improves DVH parameters of pulsed-dose-rate brachytherapy in locally advanced cervical cancer.
Lindegaard JC; Tanderup K; Nielsen SK; Haack S; Gelineck J
Int J Radiat Oncol Biol Phys; 2008 Jul; 71(3):756-64. PubMed ID: 18191335
[TBL] [Abstract][Full Text] [Related]
11. Comparison of dosimetric and clinical outcomes between short- and long-channel cylinder applicators for vaginal brachytherapy in intermediate- and high-risk endometrial cancer.
Kharouta MZ; Pham N; Nieto K; Surucu M; Mysz ML; Albuquerque K; Winder A; Liotta M; Potkul RK; Small W; Harkenrider MM
Brachytherapy; 2018; 17(4):673-679. PubMed ID: 29759329
[TBL] [Abstract][Full Text] [Related]
12. Intravaginal high-dose-rate brachytherapy for stage I endometrial cancer: a randomized study of two dose-per-fraction levels.
Sorbe B; Straumits A; Karlsson L
Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1385-9. PubMed ID: 16029797
[TBL] [Abstract][Full Text] [Related]
13. The use and advantages of a multichannel vaginal cylinder in high-dose-rate brachytherapy.
Demanes DJ; Rege S; Rodriquez RR; Schutz KL; Altieri GA; Wong T
Int J Radiat Oncol Biol Phys; 1999 Apr; 44(1):211-9. PubMed ID: 10219816
[TBL] [Abstract][Full Text] [Related]
14. A novel device for intravaginal electronic brachytherapy.
Schneider F; Fuchs H; Lorenz F; Steil V; Ziglio F; Kraus-Tiefenbacher U; Lohr F; Wenz F
Int J Radiat Oncol Biol Phys; 2009 Jul; 74(4):1298-305. PubMed ID: 19545794
[TBL] [Abstract][Full Text] [Related]
15. A new method of anatomically conformal vaginal cuff HDR brachytherapy.
Miller DA; Richardson S; Grigsby PW
Gynecol Oncol; 2010 Mar; 116(3):413-8. PubMed ID: 19892389
[TBL] [Abstract][Full Text] [Related]
16. An analysis of simulation for adjuvant intracavitary high-dose-rate brachytherapy in early-stage endometrial cancer.
Barney BM; MacDonald OK; Lee CM; Rankin J; Gaffney DK
Brachytherapy; 2007; 6(3):201-6. PubMed ID: 17681241
[TBL] [Abstract][Full Text] [Related]
17. Dosimetric advantages of using multichannel balloons compared to single-channel cylinders for high-dose-rate vaginal cuff brachytherapy.
Hou X; Liu A; Zhang F; Wong J; Chen YJ
Brachytherapy; 2016; 15(4):471-476. PubMed ID: 27066994
[TBL] [Abstract][Full Text] [Related]
18. Dosimetric impact of cylinder size in high-dose rate vaginal cuff brachytherapy (VCBT) for primary endometrial cancer.
Zhang H; Gopalakrishnan M; Lee P; Kang Z; Sathiaseelan V
J Appl Clin Med Phys; 2016 Sep; 17(5):262-272. PubMed ID: 27685113
[TBL] [Abstract][Full Text] [Related]
19. Geometric and dosimetric variations of ICRU bladder and rectum reference points in vaginal cuff brachytherapy using ovoids.
Garipagaoglu M; Tuncel N; Köseoglu FG; Gülkesen H; Kizildag AU; Toy A; Dalmaz MG
Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1607-15. PubMed ID: 15050342
[TBL] [Abstract][Full Text] [Related]
20. Influence of dose point and inverse optimization on interstitial cervical and oropharyngeal carcinoma brachytherapy.
Ahmad F; Aletti P; Charra-Brunaud C; Van der Laarse R; Lapeyre M; Hoffstetter S; Peiffert D; Nöel A
Radiother Oncol; 2004 Dec; 73(3):331-7. PubMed ID: 15588879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
